These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16801412)

  • 21. Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals.
    Cartolano GL; Cheron M; Benabid D; Leneveu M; Boisivon A;
    Clin Microbiol Infect; 2004 May; 10(5):448-51. PubMed ID: 15113324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of glycopeptide hetero-intermediate Staphylococcus aureus strains in Maltese hospitals.
    Borg MA; Zerafa R; Morrison D; Cuschieri P
    Clin Microbiol Infect; 2005 May; 11(5):405-7. PubMed ID: 15819869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of four methods for detection of teicoplanin resistance in methicillin-resistant Staphylococcus aureus.
    Charlesworth R; Warner M; Livermore DM; Wilson AP
    J Antimicrob Chemother; 2006 Jul; 58(1):186-9. PubMed ID: 16641117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compensatory mutations in agrC partly restore fitness in vitro to peptide deformylase inhibitor-resistant Staphylococcus aureus.
    Zorzet A; Andersen JM; Nilsson AI; Møller NF; Andersson DI
    J Antimicrob Chemother; 2012 Aug; 67(8):1835-42. PubMed ID: 22577101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Activity of vancomycin and teicoplanin against clinical isolates of Staphylococcus aureus in the period 1994-1999].
    Nashev D; Toshkova K; Gavrilova V
    Vutr Boles; 2000; 32(2):35-40. PubMed ID: 11227664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus.
    Fitzgibbon MM; Rossney AS; O'Connell B
    J Clin Microbiol; 2007 Oct; 45(10):3263-9. PubMed ID: 17687008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiological and clinical study of methicillin-resistant Staphylococcus aureus (MRSA) carrying VraS mutation: changes in susceptibility to glycopeptides and clinical significance.
    Kato Y; Suzuki T; Ida T; Maebashi K; Sakurai M; Shiotani J; Hayashi I
    Int J Antimicrob Agents; 2008 Jan; 31(1):64-70. PubMed ID: 18029148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Activity of vancomycin, teicoplanin and linezolid in methicillin resistant coagulase-negative Staphylococci isolates from paediatric blood cultures].
    Fajardo Olivares M; Hidalgo Orozco R; Rodríguez Garrido S; Gaona Álvarez C; Sánchez Silos RM; Hernández Rastrollo R; Martínez Tallo E; Cordero Carrasco JL
    Rev Esp Quimioter; 2012 Mar; 25(1):25-30. PubMed ID: 22488538
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An outbreak of Staphylococcus aureus strains with reduced susceptibility to glycopeptides in a French general hospital.
    Pina P; Marliere C; Vandenesch F; Bedos JP; Etienne J; Allouch PY
    Clin Infect Dis; 2000 Nov; 31(5):1306-8. PubMed ID: 11073773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selection of resistance to glycopeptide antibiotics in staphylococci.
    Biavasco F; Giovanetti E; Varaldo PE
    J Chemother; 1991 Jan; 3 Suppl 1():166-8. PubMed ID: 12041756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of oxacillin, vancomycin and teicoplanin against staphylococci isolated from patients on surgical and coronary intensive care units.
    Kucukates E; Nalan Karayel E; Gultekin N; Okuyan E; Kansiz E; Gurler N
    Int J Antimicrob Agents; 2004 Aug; 24(2):193-4. PubMed ID: 15288323
    [No Abstract]   [Full Text] [Related]  

  • 33. False synergy between vancomycin and beta-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods.
    Goldstein FW; Atoui R; Ben Ali A; Nguyen JC; Ly A; Kitzis MD
    Clin Microbiol Infect; 2004 Apr; 10(4):342-5. PubMed ID: 15059127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The ability of biofilm formation does not influence virulence of Staphylococcus aureus and host response in a mouse tissue cage infection model.
    Kristian SA; Golda T; Ferracin F; Cramton SE; Neumeister B; Peschel A; Götz F; Landmann R
    Microb Pathog; 2004 May; 36(5):237-45. PubMed ID: 15043859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
    Miyake N; Kadowaki M; Sato Y; Eriguchi Y; Nagasaki Y; Harada Y; Uchida Y; Shimono N
    Jpn J Antibiot; 2011 Aug; 64(4):231-7. PubMed ID: 22066347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial resistance and virulence markers in methicillin sensitive Staphylococcus aureus isolates associated with nasal colonization.
    Sarkar A; Raji A; Garaween G; Soge O; Rey-Ladino J; Al-Kattan W; Shibl A; Senok A
    Microb Pathog; 2016 Apr; 93():8-12. PubMed ID: 26796298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
    Drago L; De Vecchi E; Nicola L; Gismondo MR
    BMC Infect Dis; 2007 Sep; 7():111. PubMed ID: 17888153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The discriminatory power of MALDI-TOF mass spectrometry to differentiate between isogenic teicoplanin-susceptible and teicoplanin-resistant strains of methicillin-resistant Staphylococcus aureus.
    Majcherczyk PA; McKenna T; Moreillon P; Vaudaux P
    FEMS Microbiol Lett; 2006 Feb; 255(2):233-9. PubMed ID: 16448500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycopeptide resistance in Staphylococcus aureus.
    Chadwick PR; Wooster SL
    J Infect; 2000 May; 40(3):211-7. PubMed ID: 10908014
    [No Abstract]   [Full Text] [Related]  

  • 40. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
    Tiwari HK; Sen MR
    BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.